chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Troponin increased, Urine analysis normal
Clinical narrative: Clinical Summary Patient is a 80 y.o. female with a history of Alzheimer's disease, hypertension and glaucoma who presented to hospital 4/13/2023 with fever and altered mental status. Patient found to have COVID 19, labs with BMP, CBC, BMP, HFP, lipase unrevealing. LA 1.1, UA without infection. Admit VBG with pH 7.4, pCO2 and pO2 stable. CXR non-acute.  CT head with no acute intracranial findings, noted acute pansinusitis.    1. COVID 19 Infection: Presented as above. Vaccinated and boosted, denies prior COVID infections. Symptom onset 4/12/23. Admit CXR non-acute. Not requiring O2 on admit, therefore defer decadron or remdesivir. Consult to ID and started and completed course of paxlovid. Symptoms improved.  2. Sepsis: Met criteria with Temp 100.8, tachycardia on presentation. Secondary to COVID as above. CXR and UA without infection. CT head with pansinusitis. Procal negative. On Vanc/Zosyn in ED, held on further antibiotics on admit as suspect viral etiology or sepsis criteria with COVID. Given 1.5 L bolus in ED. Now dry lung strategy with COVID. Treat as discussed and monitor.   3. Acute Metabolic Encephalopathy on Chronic Dementia: Family describes 3-4 month cognitive and functional decline with history of Alzheimers dementia. Per family, prior baseline was alert and oriented with short term memory deficits. Recent baseline waxes and wanes, minimal short term memory. Family feels patient is at recent baseline on admit. Oriented to self, general location, month, year and family on admit. Continued home Remeron. Delirium precautions.  4. Oral thrush: Noted 4/15/23. Nystatin swish and spit continued. 5. Elevated Troponin: Admit Trop 19, second trop 17. Admit EKG with sinus tachycardia, no acute ischemic changes. No chest pain on admit. Suspect demand ischemia with above. No other ischemic eval planned.  6. Acute sinusitis: Diagnosed on admission. Completed Augmentin course 4/18/23. 7. Fall: Secondary to weakness at home. Unable to get off toilet and assisted to ground by family. Denied injuries or hitting head. PT/OT consulted, family interested in SNF on discharge.  8. Hypertension: Per history, continued home Cozaar with hold parameters. Monitor and titrate PRN.  9. Glaucoma: Per history, continued home eye drops.
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Chills, Fatigue, Hyperhidrosis, Pain
Clinical narrative: Patient reports of having arm swelling, sweating, chills, swollen face, pain, weakness, and fatigue
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Peripheral swelling, Swelling face
Clinical narrative: Patient reports of having arm swelling, sweating, chills, swollen face, pain, weakness, and fatigue
Age: 0.5
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT
Age: 4.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 84.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 1/11/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 1.0
Sex: M
Vaccine: DTAPHEPBIP, HEPA, HIBV, MMR, PNC15, VARCEL
Symptoms: Circumstance or information capable of leading to medication error, Product supply issue, Wrong product administered
Clinical narrative: MA that pended the order had pentcel which we don't have in our office. I attempted to fix this, however I did not pay attention to the System.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Acute kidney injury, Angiogram pulmonary abnormal, Ankylosing spondylitis, Aphonia, Asthenia
Clinical narrative: Assessment and Plan Patient is a 51 y.o. male patient of Physician No with history of diabetes, ankylosing spondylitis presented to Hospital with fevers, weakness.   Covid-19 Virus Infection Pneumonia Gram negative suspected Sepsis Date of onset of symptoms: 04/14 Symptoms present on admission: Yes, sore throat, productive cough, loss of voice, fever. Fever of 101.5 with tachycardia and leukocytosis of 17K on arrival. Date of covid positive test: 04/16 Imaging: CTPA with RLL clustered nodular opacity Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy: Not a candidate for steroids/remdesivir. Paxlovid X5 days Consultants following: ID Anticipated special isol Anticipated special isolation end date: 04/23. Discharged with azithromycin and cefdinir   AKI Creatinine 1.98, BUN 16. Likely secondary to sepsis in the setting of metformin, indomethacin use.(Patient also received contrast study). Improving creat, 1. today Hold indomethacin at dishcarge   Diabetes type 2 On metformin at home Hold metformin, A1C 6.6 SSI Ankylosing spondylitis On chronic indomethacin. Given AKI would recommend discontinuation of indomethacin. Discussed with PCP.   Thyroid nodule Right thyroid lobe nodule measuring 3.8 cm noted on CTPA study. TSH wnl. Recommend thyroid ultrasound as outpatient.   Clustered nodular opacities in the right lower lobe Likely inflammatory, on abx. Elevated procalcitonin. Follow-up CT chest recommended in 6 weeks as outpatient. F/U with PCP.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Blood creatinine, Blood thyroid stimulating hormone normal, Blood urea, COVID-19, Glycosylated haemoglobin normal
Clinical narrative: Assessment and Plan Patient is a 51 y.o. male patient of Physician No with history of diabetes, ankylosing spondylitis presented to Hospital with fevers, weakness.   Covid-19 Virus Infection Pneumonia Gram negative suspected Sepsis Date of onset of symptoms: 04/14 Symptoms present on admission: Yes, sore throat, productive cough, loss of voice, fever. Fever of 101.5 with tachycardia and leukocytosis of 17K on arrival. Date of covid positive test: 04/16 Imaging: CTPA with RLL clustered nodular opacity Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy: Not a candidate for steroids/remdesivir. Paxlovid X5 days Consultants following: ID Anticipated special isol Anticipated special isolation end date: 04/23. Discharged with azithromycin and cefdinir   AKI Creatinine 1.98, BUN 16. Likely secondary to sepsis in the setting of metformin, indomethacin use.(Patient also received contrast study). Improving creat, 1. today Hold indomethacin at dishcarge   Diabetes type 2 On metformin at home Hold metformin, A1C 6.6 SSI Ankylosing spondylitis On chronic indomethacin. Given AKI would recommend discontinuation of indomethacin. Discussed with PCP.   Thyroid nodule Right thyroid lobe nodule measuring 3.8 cm noted on CTPA study. TSH wnl. Recommend thyroid ultrasound as outpatient.   Clustered nodular opacities in the right lower lobe Likely inflammatory, on abx. Elevated procalcitonin. Follow-up CT chest recommended in 6 weeks as outpatient. F/U with PCP.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Leukocytosis, Lung opacity, Oropharyngeal pain, Pneumonia bacterial, Pneumonitis
Clinical narrative: Assessment and Plan Patient is a 51 y.o. male patient of Physician No with history of diabetes, ankylosing spondylitis presented to Hospital with fevers, weakness.   Covid-19 Virus Infection Pneumonia Gram negative suspected Sepsis Date of onset of symptoms: 04/14 Symptoms present on admission: Yes, sore throat, productive cough, loss of voice, fever. Fever of 101.5 with tachycardia and leukocytosis of 17K on arrival. Date of covid positive test: 04/16 Imaging: CTPA with RLL clustered nodular opacity Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy: Not a candidate for steroids/remdesivir. Paxlovid X5 days Consultants following: ID Anticipated special isol Anticipated special isolation end date: 04/23. Discharged with azithromycin and cefdinir   AKI Creatinine 1.98, BUN 16. Likely secondary to sepsis in the setting of metformin, indomethacin use.(Patient also received contrast study). Improving creat, 1. today Hold indomethacin at dishcarge   Diabetes type 2 On metformin at home Hold metformin, A1C 6.6 SSI Ankylosing spondylitis On chronic indomethacin. Given AKI would recommend discontinuation of indomethacin. Discussed with PCP.   Thyroid nodule Right thyroid lobe nodule measuring 3.8 cm noted on CTPA study. TSH wnl. Recommend thyroid ultrasound as outpatient.   Clustered nodular opacities in the right lower lobe Likely inflammatory, on abx. Elevated procalcitonin. Follow-up CT chest recommended in 6 weeks as outpatient. F/U with PCP.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Procalcitonin increased, Productive cough, Pulmonary mass, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Assessment and Plan Patient is a 51 y.o. male patient of Physician No with history of diabetes, ankylosing spondylitis presented to Hospital with fevers, weakness.   Covid-19 Virus Infection Pneumonia Gram negative suspected Sepsis Date of onset of symptoms: 04/14 Symptoms present on admission: Yes, sore throat, productive cough, loss of voice, fever. Fever of 101.5 with tachycardia and leukocytosis of 17K on arrival. Date of covid positive test: 04/16 Imaging: CTPA with RLL clustered nodular opacity Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy: Not a candidate for steroids/remdesivir. Paxlovid X5 days Consultants following: ID Anticipated special isol Anticipated special isolation end date: 04/23. Discharged with azithromycin and cefdinir   AKI Creatinine 1.98, BUN 16. Likely secondary to sepsis in the setting of metformin, indomethacin use.(Patient also received contrast study). Improving creat, 1. today Hold indomethacin at dishcarge   Diabetes type 2 On metformin at home Hold metformin, A1C 6.6 SSI Ankylosing spondylitis On chronic indomethacin. Given AKI would recommend discontinuation of indomethacin. Discussed with PCP.   Thyroid nodule Right thyroid lobe nodule measuring 3.8 cm noted on CTPA study. TSH wnl. Recommend thyroid ultrasound as outpatient.   Clustered nodular opacities in the right lower lobe Likely inflammatory, on abx. Elevated procalcitonin. Follow-up CT chest recommended in 6 weeks as outpatient. F/U with PCP.
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Sepsis, Tachycardia, Thyroid mass, White blood cell count increased
Clinical narrative: Assessment and Plan Patient is a 51 y.o. male patient of Physician No with history of diabetes, ankylosing spondylitis presented to Hospital with fevers, weakness.   Covid-19 Virus Infection Pneumonia Gram negative suspected Sepsis Date of onset of symptoms: 04/14 Symptoms present on admission: Yes, sore throat, productive cough, loss of voice, fever. Fever of 101.5 with tachycardia and leukocytosis of 17K on arrival. Date of covid positive test: 04/16 Imaging: CTPA with RLL clustered nodular opacity Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy: Not a candidate for steroids/remdesivir. Paxlovid X5 days Consultants following: ID Anticipated special isol Anticipated special isolation end date: 04/23. Discharged with azithromycin and cefdinir   AKI Creatinine 1.98, BUN 16. Likely secondary to sepsis in the setting of metformin, indomethacin use.(Patient also received contrast study). Improving creat, 1. today Hold indomethacin at dishcarge   Diabetes type 2 On metformin at home Hold metformin, A1C 6.6 SSI Ankylosing spondylitis On chronic indomethacin. Given AKI would recommend discontinuation of indomethacin. Discussed with PCP.   Thyroid nodule Right thyroid lobe nodule measuring 3.8 cm noted on CTPA study. TSH wnl. Recommend thyroid ultrasound as outpatient.   Clustered nodular opacities in the right lower lobe Likely inflammatory, on abx. Elevated procalcitonin. Follow-up CT chest recommended in 6 weeks as outpatient. F/U with PCP.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 0.58
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 0.83
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 0.67
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given beyond use date, no adverse reaction
Age: 1.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Abdominal pain upper, Diarrhoea, Headache, Hyperhidrosis, Nausea
Clinical narrative: Fever 105.2, diaphoretic, nausea, diarrhea, head pain, stomach pain  Treated with fluids and acetaminophen and ibuprofen brought fever down gradually by next morning only slightly elevated temp of 101 that was at baseline by midday. All other symptoms were relieved by morning.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Pyrexia
Clinical narrative: Fever 105.2, diaphoretic, nausea, diarrhea, head pain, stomach pain  Treated with fluids and acetaminophen and ibuprofen brought fever down gradually by next morning only slightly elevated temp of 101 that was at baseline by midday. All other symptoms were relieved by morning.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Back pain, Chills, Dizziness, Headache
Clinical narrative: Starting around 10:30 pm the night of the vaccination, experienced a sudden optical migraine in both eyes that lasted about 45 mins, which turned I to a severe headache. At around 5:15 am the following morning, woke up to severe cramping in the legs, swelling in the knees, pain in the lower back and legs, shaking, chills, arm pain at injection sight, and fever which lasted the majority of the day. These symptoms finally subsided around 6 pm, but started again around 12:30 am July 13th, until I finally fell asleep around 4 am. At 9 am, I awoke with a severe headache and pain in the lower back/hip area, pain in the left arm and occasional light headed while moving. I am trying to contact my family physician to find out what I need to do.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Joint swelling, Muscle spasms, Ophthalmic migraine, Pain in extremity
Clinical narrative: Starting around 10:30 pm the night of the vaccination, experienced a sudden optical migraine in both eyes that lasted about 45 mins, which turned I to a severe headache. At around 5:15 am the following morning, woke up to severe cramping in the legs, swelling in the knees, pain in the lower back and legs, shaking, chills, arm pain at injection sight, and fever which lasted the majority of the day. These symptoms finally subsided around 6 pm, but started again around 12:30 am July 13th, until I finally fell asleep around 4 am. At 9 am, I awoke with a severe headache and pain in the lower back/hip area, pain in the left arm and occasional light headed while moving. I am trying to contact my family physician to find out what I need to do.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Tremor
Clinical narrative: Starting around 10:30 pm the night of the vaccination, experienced a sudden optical migraine in both eyes that lasted about 45 mins, which turned I to a severe headache. At around 5:15 am the following morning, woke up to severe cramping in the legs, swelling in the knees, pain in the lower back and legs, shaking, chills, arm pain at injection sight, and fever which lasted the majority of the day. These symptoms finally subsided around 6 pm, but started again around 12:30 am July 13th, until I finally fell asleep around 4 am. At 9 am, I awoke with a severe headache and pain in the lower back/hip area, pain in the left arm and occasional light headed while moving. I am trying to contact my family physician to find out what I need to do.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram pulmonary normal, Asthenia, Bladder catheterisation, Blood glucose increased, Blood thyroid stimulating hormone decreased
Clinical narrative: Patient is a 88 y.o. female patient with history of DM2, HTN, DJD s/p THA 4/6/2023, Chronic back pain who presented to Hospital with syncope.  Found to be COVID-positive.  With adjustment of home medications and treatment of COVID patient symptoms improved.   Syncope Secondary to bradycardia and dehydration in setting of  COVID reportedly sinus pauses seen while in transport. Recent orthopedic surgery noted, poor intake. May also consider component of orthostasis.   EKG NSR 1 AVB on admisison CTPA neg for PE. Chronic incidental findings reviewed.  Head CT and CT cervical non-acute  NM Stress 9/2021 no evidence of ischemia.  Echo 9/2021 normal LV fn, EF~60%, mild to mod MR, TR Cardiology evaluated Patient had bradycardia while on lopressor and despite decreasing doses. Discussed with cardiology. Will discontinue BB as the only indication to be on Lopressor seems to be hypertension. HR 60 -65 after discontinuing BB No more episodes of syncope 30 day holter monitor on discharge, cardiolgoy office to arrange Cardiology signed off COVID 19 infection without pneumonia Covid-19 Virus Infection Date of onset of symptoms: 4/11/23 Symptoms present on admission: generalized weakness, nasuea, syncope Date of covid positive test: 4/12/23 Vaccination status: vaccinated Imaging: CT chest: no PE or infiltrates Oxygen requirements on admission: 3 L NC Current oxygen requirements: RA with sats >92% Medical therapy: remdesivir and steroids Consultants following: none Anticipated special isolation end date: 4/21/23   Post-op urinary retention  Foley was placed on admission. Removed 4/15   DM2 A1c 6.5 (3/2023) Admit glucose 218 Restart home regimen   HTN BP on higher side Continue home Norvasc increased to 10 mg today, stopped Toprol xl last dose 4/14 Started on lisinopril 4/14 given history of Diabetes.  Increased lisinopril to 40 mg on 4/16/23 PRN hydralazine   DJD S/p left THA 4/6/23 SCD's dvt ppx  Continue pain control    Chronic back pain  Hx of spinal cord stimulator  Continue home Oxycodone (NARx). Of note, pt with recent increase in dosing to cover for post-operative pain. Will restart post-op dosing schedule. Monitor for oversedation    Thyroid nodule  As noted on admit CT cervical  Recent TSH 1.167 (3/2023) Recommend non-emergent thyroid ultrasound
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bradycardia, COVID-19, Cardiac stress test, Computerised tomogram head normal, Computerised tomogram spine abnormal
Clinical narrative: Patient is a 88 y.o. female patient with history of DM2, HTN, DJD s/p THA 4/6/2023, Chronic back pain who presented to Hospital with syncope.  Found to be COVID-positive.  With adjustment of home medications and treatment of COVID patient symptoms improved.   Syncope Secondary to bradycardia and dehydration in setting of  COVID reportedly sinus pauses seen while in transport. Recent orthopedic surgery noted, poor intake. May also consider component of orthostasis.   EKG NSR 1 AVB on admisison CTPA neg for PE. Chronic incidental findings reviewed.  Head CT and CT cervical non-acute  NM Stress 9/2021 no evidence of ischemia.  Echo 9/2021 normal LV fn, EF~60%, mild to mod MR, TR Cardiology evaluated Patient had bradycardia while on lopressor and despite decreasing doses. Discussed with cardiology. Will discontinue BB as the only indication to be on Lopressor seems to be hypertension. HR 60 -65 after discontinuing BB No more episodes of syncope 30 day holter monitor on discharge, cardiolgoy office to arrange Cardiology signed off COVID 19 infection without pneumonia Covid-19 Virus Infection Date of onset of symptoms: 4/11/23 Symptoms present on admission: generalized weakness, nasuea, syncope Date of covid positive test: 4/12/23 Vaccination status: vaccinated Imaging: CT chest: no PE or infiltrates Oxygen requirements on admission: 3 L NC Current oxygen requirements: RA with sats >92% Medical therapy: remdesivir and steroids Consultants following: none Anticipated special isolation end date: 4/21/23   Post-op urinary retention  Foley was placed on admission. Removed 4/15   DM2 A1c 6.5 (3/2023) Admit glucose 218 Restart home regimen   HTN BP on higher side Continue home Norvasc increased to 10 mg today, stopped Toprol xl last dose 4/14 Started on lisinopril 4/14 given history of Diabetes.  Increased lisinopril to 40 mg on 4/16/23 PRN hydralazine   DJD S/p left THA 4/6/23 SCD's dvt ppx  Continue pain control    Chronic back pain  Hx of spinal cord stimulator  Continue home Oxycodone (NARx). Of note, pt with recent increase in dosing to cover for post-operative pain. Will restart post-op dosing schedule. Monitor for oversedation    Thyroid nodule  As noted on admit CT cervical  Recent TSH 1.167 (3/2023) Recommend non-emergent thyroid ultrasound
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram thorax normal, Dehydration, Echocardiogram abnormal, Ejection fraction normal, Electrocardiogram normal
Clinical narrative: Patient is a 88 y.o. female patient with history of DM2, HTN, DJD s/p THA 4/6/2023, Chronic back pain who presented to Hospital with syncope.  Found to be COVID-positive.  With adjustment of home medications and treatment of COVID patient symptoms improved.   Syncope Secondary to bradycardia and dehydration in setting of  COVID reportedly sinus pauses seen while in transport. Recent orthopedic surgery noted, poor intake. May also consider component of orthostasis.   EKG NSR 1 AVB on admisison CTPA neg for PE. Chronic incidental findings reviewed.  Head CT and CT cervical non-acute  NM Stress 9/2021 no evidence of ischemia.  Echo 9/2021 normal LV fn, EF~60%, mild to mod MR, TR Cardiology evaluated Patient had bradycardia while on lopressor and despite decreasing doses. Discussed with cardiology. Will discontinue BB as the only indication to be on Lopressor seems to be hypertension. HR 60 -65 after discontinuing BB No more episodes of syncope 30 day holter monitor on discharge, cardiolgoy office to arrange Cardiology signed off COVID 19 infection without pneumonia Covid-19 Virus Infection Date of onset of symptoms: 4/11/23 Symptoms present on admission: generalized weakness, nasuea, syncope Date of covid positive test: 4/12/23 Vaccination status: vaccinated Imaging: CT chest: no PE or infiltrates Oxygen requirements on admission: 3 L NC Current oxygen requirements: RA with sats >92% Medical therapy: remdesivir and steroids Consultants following: none Anticipated special isolation end date: 4/21/23   Post-op urinary retention  Foley was placed on admission. Removed 4/15   DM2 A1c 6.5 (3/2023) Admit glucose 218 Restart home regimen   HTN BP on higher side Continue home Norvasc increased to 10 mg today, stopped Toprol xl last dose 4/14 Started on lisinopril 4/14 given history of Diabetes.  Increased lisinopril to 40 mg on 4/16/23 PRN hydralazine   DJD S/p left THA 4/6/23 SCD's dvt ppx  Continue pain control    Chronic back pain  Hx of spinal cord stimulator  Continue home Oxycodone (NARx). Of note, pt with recent increase in dosing to cover for post-operative pain. Will restart post-op dosing schedule. Monitor for oversedation    Thyroid nodule  As noted on admit CT cervical  Recent TSH 1.167 (3/2023) Recommend non-emergent thyroid ultrasound
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Glycosylated haemoglobin, Hypertension, Mitral valve incompetence, Nausea, SARS-CoV-2 test positive
Clinical narrative: Patient is a 88 y.o. female patient with history of DM2, HTN, DJD s/p THA 4/6/2023, Chronic back pain who presented to Hospital with syncope.  Found to be COVID-positive.  With adjustment of home medications and treatment of COVID patient symptoms improved.   Syncope Secondary to bradycardia and dehydration in setting of  COVID reportedly sinus pauses seen while in transport. Recent orthopedic surgery noted, poor intake. May also consider component of orthostasis.   EKG NSR 1 AVB on admisison CTPA neg for PE. Chronic incidental findings reviewed.  Head CT and CT cervical non-acute  NM Stress 9/2021 no evidence of ischemia.  Echo 9/2021 normal LV fn, EF~60%, mild to mod MR, TR Cardiology evaluated Patient had bradycardia while on lopressor and despite decreasing doses. Discussed with cardiology. Will discontinue BB as the only indication to be on Lopressor seems to be hypertension. HR 60 -65 after discontinuing BB No more episodes of syncope 30 day holter monitor on discharge, cardiolgoy office to arrange Cardiology signed off COVID 19 infection without pneumonia Covid-19 Virus Infection Date of onset of symptoms: 4/11/23 Symptoms present on admission: generalized weakness, nasuea, syncope Date of covid positive test: 4/12/23 Vaccination status: vaccinated Imaging: CT chest: no PE or infiltrates Oxygen requirements on admission: 3 L NC Current oxygen requirements: RA with sats >92% Medical therapy: remdesivir and steroids Consultants following: none Anticipated special isolation end date: 4/21/23   Post-op urinary retention  Foley was placed on admission. Removed 4/15   DM2 A1c 6.5 (3/2023) Admit glucose 218 Restart home regimen   HTN BP on higher side Continue home Norvasc increased to 10 mg today, stopped Toprol xl last dose 4/14 Started on lisinopril 4/14 given history of Diabetes.  Increased lisinopril to 40 mg on 4/16/23 PRN hydralazine   DJD S/p left THA 4/6/23 SCD's dvt ppx  Continue pain control    Chronic back pain  Hx of spinal cord stimulator  Continue home Oxycodone (NARx). Of note, pt with recent increase in dosing to cover for post-operative pain. Will restart post-op dosing schedule. Monitor for oversedation    Thyroid nodule  As noted on admit CT cervical  Recent TSH 1.167 (3/2023) Recommend non-emergent thyroid ultrasound
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sinus arrest, Syncope, Thyroid mass, Tricuspid valve incompetence, Urinary retention postoperative
Clinical narrative: Patient is a 88 y.o. female patient with history of DM2, HTN, DJD s/p THA 4/6/2023, Chronic back pain who presented to Hospital with syncope.  Found to be COVID-positive.  With adjustment of home medications and treatment of COVID patient symptoms improved.   Syncope Secondary to bradycardia and dehydration in setting of  COVID reportedly sinus pauses seen while in transport. Recent orthopedic surgery noted, poor intake. May also consider component of orthostasis.   EKG NSR 1 AVB on admisison CTPA neg for PE. Chronic incidental findings reviewed.  Head CT and CT cervical non-acute  NM Stress 9/2021 no evidence of ischemia.  Echo 9/2021 normal LV fn, EF~60%, mild to mod MR, TR Cardiology evaluated Patient had bradycardia while on lopressor and despite decreasing doses. Discussed with cardiology. Will discontinue BB as the only indication to be on Lopressor seems to be hypertension. HR 60 -65 after discontinuing BB No more episodes of syncope 30 day holter monitor on discharge, cardiolgoy office to arrange Cardiology signed off COVID 19 infection without pneumonia Covid-19 Virus Infection Date of onset of symptoms: 4/11/23 Symptoms present on admission: generalized weakness, nasuea, syncope Date of covid positive test: 4/12/23 Vaccination status: vaccinated Imaging: CT chest: no PE or infiltrates Oxygen requirements on admission: 3 L NC Current oxygen requirements: RA with sats >92% Medical therapy: remdesivir and steroids Consultants following: none Anticipated special isolation end date: 4/21/23   Post-op urinary retention  Foley was placed on admission. Removed 4/15   DM2 A1c 6.5 (3/2023) Admit glucose 218 Restart home regimen   HTN BP on higher side Continue home Norvasc increased to 10 mg today, stopped Toprol xl last dose 4/14 Started on lisinopril 4/14 given history of Diabetes.  Increased lisinopril to 40 mg on 4/16/23 PRN hydralazine   DJD S/p left THA 4/6/23 SCD's dvt ppx  Continue pain control    Chronic back pain  Hx of spinal cord stimulator  Continue home Oxycodone (NARx). Of note, pt with recent increase in dosing to cover for post-operative pain. Will restart post-op dosing schedule. Monitor for oversedation    Thyroid nodule  As noted on admit CT cervical  Recent TSH 1.167 (3/2023) Recommend non-emergent thyroid ultrasound
Age: 1.17
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 21.0
Sex: F
Vaccine: HEPA
Symptoms: Dizziness, Feeling hot, Hyperhidrosis, Nausea, Pallor
Clinical narrative: Patient was administered Hep A vaccine as above and ceftriaxone 500 mg in lidocaine 1% IM. Known to have a documented past non-allergic reaction to penicillin. Both vaccine and antibiotic were administered within 1-2 minutes of each other. Patient sat in clinic lobby to be monitored for 15 minutes after receiving injections. 15 minutes following injection she experienced sense of feeling hot, nauseated, lightheaded, and diaphoretic. Pallor noted by staff. Out of concern for anaphylaxis epi pen was given and she was transferred to hospital for recovery. VS stable throughout incident with normal BP and oxygenation. No abnormal VS except tachycardia (HR 100).
Age: 21.0
Sex: F
Vaccine: HEPA
Symptoms: Tachycardia
Clinical narrative: Patient was administered Hep A vaccine as above and ceftriaxone 500 mg in lidocaine 1% IM. Known to have a documented past non-allergic reaction to penicillin. Both vaccine and antibiotic were administered within 1-2 minutes of each other. Patient sat in clinic lobby to be monitored for 15 minutes after receiving injections. 15 minutes following injection she experienced sense of feeling hot, nauseated, lightheaded, and diaphoretic. Pallor noted by staff. Out of concern for anaphylaxis epi pen was given and she was transferred to hospital for recovery. VS stable throughout incident with normal BP and oxygenation. No abnormal VS except tachycardia (HR 100).
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 90.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest pain, Death, Pulmonary embolism
Clinical narrative: Patient entered hospital 6/20 complaining of chest pain. Diagnosed with pulmonary embolism. Patient died 6/28.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angina unstable
Clinical narrative: UNSTABLE ANGINA
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: Headache, fatigue, diarrhea, nausea,
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE RESPIRATORY FAILURE HYPOXIA
Age: 25.0
Sex: M
Vaccine: JEV1, RAB
Symptoms: Chest discomfort, Dizziness, Dysstasia, Nausea, Pruritus
Clinical narrative: 25 y/o male ambulates to facility 1 hour after receiving 2nd shot of JEV and 3rd shot of Rabies in right arm. Member felt itchy and took oral Benadryl, after which he presented to Facility. Member presented with hives on arms and chest. Member noted to have runny nose. Member self-reports nausea, dizziness, and unable to stand up. Upper airway noted to be intact without SOB, chest tightness noted in lower chest. Member rushed to restroom and promptly vomited and passed stool. Mild chest tightness resolved following vomiting and passing of stool. No itchiness of lips, tongue or palate, edema of lips, tongue or uvula. No tightness in throat. No dysphagia. Member monitored in Facility for 1.5 hours and told to return should symptoms come back.
Age: 25.0
Sex: M
Vaccine: JEV1, RAB
Symptoms: Rhinorrhoea, Urticaria, Vomiting
Clinical narrative: 25 y/o male ambulates to facility 1 hour after receiving 2nd shot of JEV and 3rd shot of Rabies in right arm. Member felt itchy and took oral Benadryl, after which he presented to Facility. Member presented with hives on arms and chest. Member noted to have runny nose. Member self-reports nausea, dizziness, and unable to stand up. Upper airway noted to be intact without SOB, chest tightness noted in lower chest. Member rushed to restroom and promptly vomited and passed stool. Mild chest tightness resolved following vomiting and passing of stool. No itchiness of lips, tongue or palate, edema of lips, tongue or uvula. No tightness in throat. No dysphagia. Member monitored in Facility for 1.5 hours and told to return should symptoms come back.
Age: 0.58
Sex: F
Vaccine: UNK
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Incorrect vaccine administerd. Chiold had not recieved any previous COVID-19 vaccines. Vaccine administerd was Moderna COVID-19 Bivalent ages: 6 months through 5 years pink cap with yellow label 10mcg/0.2mL. No treatment required.
Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 21.0
Sex: M
Vaccine: HPV9
Symptoms: Diarrhoea, Extrasystoles, Pyrexia
Clinical narrative: Reports sensation of heart skipping beat since last night at 11pm into 11am this morning. Also with fever of 100-101. Took advil and tylenol with relief. No further cardiac symptoms since this AM (now 4pm). Also with diarrhea, however thinks this was triggered by spicy food he had. Feeling improved now, no other symptoms. Had HPV vaccine 2 days ago (1 day prior to symptom onset).
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia, Respiratory failure
Clinical narrative: RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT ALLERGIC REACTION, SUBSEQ
Age: 0.83
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Dose 0.2ml/10mcg administered. Based on vaccination status, 0.25ml/25mcg is recommended. No adverse effect.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic fatigue syndrome, Intervertebral disc protrusion
Clinical narrative: Chronic fatigue syndrome: within 2 months of 2nd dose but diagnosed February 2023  herniated spinal disks: July 2023-adverse effect of chronic fatigue syndrome
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Deep vein thrombosis, Hypoxia
Clinical narrative: ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN HYPOXEMIA
Age: 1.0
Sex: F
Vaccine: COVID19-2
Symptoms: Interchange of vaccine products
Clinical narrative: First dose pfizer, 2nd dose Moderna, No side effects, re-vaccination recommended
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given past beyond use date
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine given past beyond use date
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Confusional state, Crying, Facial pain, Fall, Immediate post-injection reaction
Clinical narrative: Patient was nervous prior to getting vaccines, patient was distracting herself by being on her phone while I was about to inject vaccines. Injected MenQuadfi and patient was ok and then I injected Bexsero, and patient was still doing ok. She did complain about the vaccines hurting as they were administered. Did a Tuberculosis testing on patient as well, as i removed needle after administrating it, patient started to slowly lean and collapsed to the floor.  Patient was picked up and sat down and was crying and was feeling pain in her face, since she collapsed face down. Nurse came in to see how patient was feeling, patient stated she was ok and that she only felt pain on her face. We asked her if she was feeling dizzy or nauseous or having an head pain. Patient stated no.  She was only confused on why she had collapsed she stated that all she remembered was hitting the floor. Patient was kept in the facility for a few more minutes to make sure she was ok to leave home.  Patient was advised to go to the ER if she experiences nausea, dizziness and headaches.
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Injection site pain, Syncope
Clinical narrative: Patient was nervous prior to getting vaccines, patient was distracting herself by being on her phone while I was about to inject vaccines. Injected MenQuadfi and patient was ok and then I injected Bexsero, and patient was still doing ok. She did complain about the vaccines hurting as they were administered. Did a Tuberculosis testing on patient as well, as i removed needle after administrating it, patient started to slowly lean and collapsed to the floor.  Patient was picked up and sat down and was crying and was feeling pain in her face, since she collapsed face down. Nurse came in to see how patient was feeling, patient stated she was ok and that she only felt pain on her face. We asked her if she was feeling dizzy or nauseous or having an head pain. Patient stated no.  She was only confused on why she had collapsed she stated that all she remembered was hitting the floor. Patient was kept in the facility for a few more minutes to make sure she was ok to leave home.  Patient was advised to go to the ER if she experiences nausea, dizziness and headaches.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Injection site reaction, Pruritus, Urticaria
Clinical narrative: Developed hives at the injection site within 24 hrs, started small then increased in size and amount. Went to urgent care on 7/12/23 and was given a steroid, which is helping the itching.  Mother indicated that child was given Benadryl when areas began to appear.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given past beyond use date
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Magnetic resonance imaging head normal
Clinical narrative: Anosmia - Lost sense of smell within days of booster shot. Not sure of exact date but, I have no recollection of smelling anything in the month of September so, I lost my sense of smell within days of the 08/25/22 injection date. I had not head trauma, injuries, or infections  at the time of the injection or thereafter to account for the loss of smell that followed.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Feeding disorder, Gastrointestinal inflammation, Headache, Nausea
Clinical narrative: Intestines inflammation, not being able to eat, Daily, nausea, headache and fever.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, X-ray
Clinical narrative: Intestines inflammation, not being able to eat, Daily, nausea, headache and fever.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given past beyond use date
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine given past beyond use date
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paresis, Hemiparesis, Idiopathic partial epilepsy, Status epilepticus
Clinical narrative: R29.810 RIGHT FACIAL MUSCLE WEAKNESS 4/1/2023 RIGHT FACIAL MUSCLE WEAKNESS G40.001 EPILEPSY, PARTIAL IDIOPATHIC W STATUS EPILEPTICUS 4/3/2023 RIGHT FACIAL MUSCLE WEAKNESS
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given past beyond use date
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine given past beyond use date
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Hypertension, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 4/22/2023 HTN (HYPERTENSION) I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/22/2023 HTN (HYPERTENSION)
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Coronary artery disease
Clinical narrative: ANGINA, UNSPECIFIED 3/28/2023 ANGINA, UNSPECIFIED CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches and pains in head
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Osteoarthritis
Clinical narrative: HYPOTENSION 4/11/2023 OSTEOARTHRITIS OF LEFT HIP
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Osteoarthritis
Clinical narrative: OBSTRUCTIVE SLEEP APNEA 10/31/2022 OSTEOARTHRITIS OF LEFT HIP
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Blindness, Cyanosis, Dizziness, Electrocardiogram normal, Exposure to communicable disease
Clinical narrative: From ER note:  Initial chief complaint was Hives (Meningococcal vaccine on Friday. Saturday "vision just blacked out but still conscious", hands "felt hot". Vomiting and fainting on Sunday, hives appeared to inner arms. Discoloration to arms and legs "they looked purple but then it went away", hives spread to arms and legs now. 15mL of Bendryl at 1315 today for allergies. Hx of allergies of hives and edema as reaction to cold, no allergy symptoms for 4 months until last 3 days. Pediatrician referred to ER for possible infection.), Fainting, Skin problem, and Vomiting     Patient is a 13 year old biological male who presents with hives.  Three days ago, the patient received meningococcal vaccine.  Since then, he is had 2 episodes of presyncope where he has felt lightheaded and like there was a heaviness in his extremities; he has never actually lost consciousness however. Onset after shower. Two days ago, he reports single episode where he vomited 3 times; he is otherwise had no vomiting besides this.  He also denies any diarrhea or any bleeding. No palpitations. No family history of sudden cardiac death or cardiac issues at early age. Today, while walking in the emergency department, he had a transient episode where he developed some blue discoloration on his right calf that has since resolved. Symptoms resolved. He otherwise denies any recent fevers, chills, or neck pain.  Of note, he did have brief contact in the last week with someone who is being treated in the hospital for meningococcus. History of angioedema and hives with cold exposure and hand swelling with minor trauma.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Feeling hot, Limb discomfort, Presyncope, Skin discolouration, Skin disorder
Clinical narrative: From ER note:  Initial chief complaint was Hives (Meningococcal vaccine on Friday. Saturday "vision just blacked out but still conscious", hands "felt hot". Vomiting and fainting on Sunday, hives appeared to inner arms. Discoloration to arms and legs "they looked purple but then it went away", hives spread to arms and legs now. 15mL of Bendryl at 1315 today for allergies. Hx of allergies of hives and edema as reaction to cold, no allergy symptoms for 4 months until last 3 days. Pediatrician referred to ER for possible infection.), Fainting, Skin problem, and Vomiting     Patient is a 13 year old biological male who presents with hives.  Three days ago, the patient received meningococcal vaccine.  Since then, he is had 2 episodes of presyncope where he has felt lightheaded and like there was a heaviness in his extremities; he has never actually lost consciousness however. Onset after shower. Two days ago, he reports single episode where he vomited 3 times; he is otherwise had no vomiting besides this.  He also denies any diarrhea or any bleeding. No palpitations. No family history of sudden cardiac death or cardiac issues at early age. Today, while walking in the emergency department, he had a transient episode where he developed some blue discoloration on his right calf that has since resolved. Symptoms resolved. He otherwise denies any recent fevers, chills, or neck pain.  Of note, he did have brief contact in the last week with someone who is being treated in the hospital for meningococcus. History of angioedema and hives with cold exposure and hand swelling with minor trauma.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Syncope, Urticaria, Vomiting
Clinical narrative: From ER note:  Initial chief complaint was Hives (Meningococcal vaccine on Friday. Saturday "vision just blacked out but still conscious", hands "felt hot". Vomiting and fainting on Sunday, hives appeared to inner arms. Discoloration to arms and legs "they looked purple but then it went away", hives spread to arms and legs now. 15mL of Bendryl at 1315 today for allergies. Hx of allergies of hives and edema as reaction to cold, no allergy symptoms for 4 months until last 3 days. Pediatrician referred to ER for possible infection.), Fainting, Skin problem, and Vomiting     Patient is a 13 year old biological male who presents with hives.  Three days ago, the patient received meningococcal vaccine.  Since then, he is had 2 episodes of presyncope where he has felt lightheaded and like there was a heaviness in his extremities; he has never actually lost consciousness however. Onset after shower. Two days ago, he reports single episode where he vomited 3 times; he is otherwise had no vomiting besides this.  He also denies any diarrhea or any bleeding. No palpitations. No family history of sudden cardiac death or cardiac issues at early age. Today, while walking in the emergency department, he had a transient episode where he developed some blue discoloration on his right calf that has since resolved. Symptoms resolved. He otherwise denies any recent fevers, chills, or neck pain.  Of note, he did have brief contact in the last week with someone who is being treated in the hospital for meningococcus. History of angioedema and hives with cold exposure and hand swelling with minor trauma.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site reaction
Clinical narrative: pt had symptoms the day after Shingrix- injection site reaction with redness
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Granuloma annulare
Clinical narrative: I have developed generalized Granuloma Annulare
Age: 1.58
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient w/ left thigh redness and mild swelling starting about 18 hours after receiving dTAP vaccine in left thigh.  Area appeared somewhat pruritic as patient was scratching at area frequently. No apparent pain.
Age: 74.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: fever
Age: 57.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Arthritis, Loss of personal independence in daily activities, Magnetic resonance imaging abnormal, Mobility decreased
Clinical narrative: Pt reports that the same day after she had her vaccines on her last visit on 10-14-2022 she started having strong shoulder pain and could not elevate her arm above her head. Since that time she has been trying stretching and topical pain creams and has noticed it has gotten a little bit better, but still to this day she cannot elevate her arm and still has significant pain.   It is difficult for her to do anything with that arm that involves elevation of her arm. She has never had problems with this shoulder in the past and she has not had any injuries